Search Results 901-910 of 15312 for alt

  1. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    Liver function test abnormalities: ALT and/or AST >1.5 × ULN for age and gender. Positive anti-double-stranded deoxyribonucleic acid (anti-dsDNA) antibody ...

  2. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 × ULN; AST and ALT ≤ 5 × ULN if liver metastases are present.. Serum creatinine ...

  3. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

    AST/ALT (SGOT/SGPT) < 2.5 x ULN for the reference laboratory or < 5 x ULN in the presence of liver metastases; Serum creatinine < 1.5 x ULN. No 'active' CNS ...

  4. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

    Serum alanine transaminase (ALT) >2.5x ULN;; Total bilirubin >1.5x ULN (unless due to Gilbert's Syndrome). Has received other anti-cancer therapy within the ...

  5. Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    Hepatic: alanine aminotransferase (ALT), and aspartate aminotransferase (AST) > 2.5 x ULN, total serum bilirubin > 1.5 x ULN (patients with Gilbert's ...

  6. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1500/mcL; · Hemoglobin ≥ 9.0 g/dL; · Platelets ≥ 100,000/mcL; · Total bilirubin ≤ 1.5 x the upper limit of normal (ULN); · SGPT (ALT) ...

  7. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    AST/SGOT and ALT/SGPT ≤ 2.5 x ULN or ≤ 5 x ULN if liver metastases. Transfusion and/or erythropoietin not permitted within 1 week prior to blood draw.

  8. Myositis Interstitial Lung Disease Nintedanib Trial - Mayo Clinic

    ... ALT by CK levels (adjusted as x ULN) should be \< 2.0 and gamma-glutamyl transferase \< 2.0 x ULN. 2. Bilirubin \> 1.5 x ULN at screening 3. Creatinine ...

  9. A Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures - Mayo Clinic

    Participation eligibility · AST or ALT ≥ 2 x ULN; · Total bilirubin ≥ 1.5 x ULN. · Females: Hemoglobin < 11 g/dL | Males: hemoglobin < 12 g/dL; · White blood cell ...

  10. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

    AST/ALT ≤ 3 x ULN; Total bilirubin <1.5 x ULN (except subjects with Gilbert Syndrome who can have total bilirubin <3.0 mg/deciliter). Women of childbearing ...